Not just a high

June 30th, 2010 by fernando

In science’s struggle to keep up with life on the streets, smoking cannabis for medical purposes stands as Exhibit A.

Medical use of cannabis has taken on momentum of its own, surging ahead of scientists’ ability to measure the drug’s benefits. The pace has been a little too quick for some, who see medicinal joints as a punch line, a ruse to free up access to a recreational drug.

But while the medical marijuana movement has been generating political news, some researchers have been quietly moving in new directions — testing cannabis and its derivatives against a host of diseases. The scientific literature now brims with potential uses for cannabis that extend beyond its well-known abilities to fend off nausea and block pain in people with cancer and AIDS. Cannabis derivatives may combat multiple sclerosis, Crohn’s disease and other inflammatory conditions, the new research finds. Cannabis may even kill cancerous tumors.

Many in the scientific community are now keen to see if this potential will be fulfilled, but they haven’t always been. Pharmacologist Roger Pertwee of the University of Aberdeen in Scotland recalls attending scientific conferences 30 years ago, eager to present his latest findings on the therapeutic effects of cannabis. It was a hard sell.

“Our talks would be scheduled at the end of the day, and our posters would be stuck in the corner somewhere,” he says. “That’s all changed.”

continue reading…

Posted in Marijuana, Psychedelic Research having no comments »

Ketamine-Assisted Psychotherapy Has a Positive Influence on the Treatment of Heroin Addiction

June 17th, 2010 by fernando

It sounds strange that a drug addiction could be successfully combated using another recreational drug, but it appears that certain psychedelic drugs can have a positive influence when combined with psychotherapy.

Although much of this research has been conducted before the 1970s and has typically focused on the use of LSD, recently psychiatrists from the St. Petersburg State Pavlov Medical University have tested the use of the drug ketamine.

Ketamine is typically used as a general anesthetic, but sub-anesthetic doses of it can produce psychedelic experiences.

The study was conducted by Evgeny M. Krupitsky, Andrei M. Burakov, Igor V. Dunaevsky, Tatyana N. Romanova, Tatyana Y. Slavina, and Alexander Y. Grinenko. It was published in the Journal of Psychoactive Drugs in 2007.

Previous research conducted by Krupitsky found that ketamine-assisted psychotherapy could be an effective treatment for heroin addiction.

This study was conducted to examine whether the addition of a psychedelic experience to psychotherapy provided a one time boost to the treatment or if continuing to administer ketamine during psychotherapy would increase the effect of the treatment.

Krupitsky and his colleagues provided an initial ketamine-assisted psychotherapy session to 59 heroin dependent inpatients from the Leningrad Regional Center of Addictions.

“Before the first ketamine session, participants received five hours of psychotherapy focused on the participants’ addictions to prepare them for the ketamine session, and they recieved five hours of psychotherapy after the first ketamine session to help them to interpret their experience,” as they explain.

The ketamine-assisted psychotherapy session itself lasted for about one and a half to two hours.

After their initial ketamine session, roughly half of the participants received two additional sessions of ketamine-assisted therapy, while the other half received two sessions of psychotherapy without the use of ketamine.

After a one year follow up, Krupitsky and his colleagues found that 50% of those who received multiple sessions of ketamine-assisted therapy remained abstinent compared to 22.2% of those who received only a single session. Traditional forms of heroin treatment, such as the use of naltrexone, typically have abstinence rates of about 20%.

But how would using a psychedelic substance such as ketamine aid psychotherapy?

“People have reported experiencing violent or rapid travel through tunnels or corridors, derealization, extreme depersonalization associated with intense fear or euphoria, and feeling connected to God or a higher power. The transformative experiences often began with extreme fear, including fear of the world ending or apocalypse, and often ended in an experience of rebirth associated with oceanic, or positively experienced, ego loss and boundlessness,” Krupitsky and his colleagues describe.

“The ketamine experience is similar to some near-death experiences, and it may produce a positive shift in the participant’s understanding of the meaning of life, life purposes, and spiritual development through mechanisms similar to those seen with near-death experiences.”

Reference: (PSYPOST)

Krupitsky, E.M., Burakov, A.M., Dunaevsky, I.V., Romanova, T.N., Slavina, T.Y. & Grinenko, A.Y. (2007). Single veruses repeated sessions of ketamine-assisted psychotherapy for people with heroin dependence. Journal of Psychoactive Drugs, Vol 39, No 1: 13-19.

Posted in Ketamine having 2 comments »

From Neurons to Nirvana

June 4th, 2010 by fernando

Check out the website here

Posted in Psychedelic Society having no comments »

Psychointegrator on Playboy Magazine!

May 27th, 2010 by fernando

That’s right! Psychedelic Medicine News got a letter published on Playboy’s issue from June 2010. It was a comment on their latest article ‘Psychedelic Renaissance’ that came out in April. For those that are getting the magazine, check out page 24! Let’s get this bunny stoned!!

Posted in Messages having no comments »

About Psychedelic Medicine News

Psychedelic Medicine News is a website promoting the healthy use of psychedelics. It is concentrating all reliable, truly informative news I find in the Internet, turning it into a reference to the psychedelic community and the world. It is an attempt to bring focus into the question of validity of the real benefits of consuming this sacred substances, and how much more we can explore of our minds if we humble ourselves to the teachings of psychedelic/entheogenic/psychointegrating compounds.